Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mavenclad
Pharma
Merck KGaA's new CEO Beckmann emphasizes reliance on M&A
Merck KGaA is emphasizing the importance of M&A to stock its early- to mid-stage pharma pipeline, the company said on Wednesday.
Kevin Dunleavy
May 13, 2026 11:54am
Merck KGaA expects Mavenclad generics to deal serious blow in US
Mar 5, 2026 11:30am
Merck KGaA tweaks 2025 forecast as geopolitical concerns mount
May 15, 2025 1:20pm
Selma Blair joins EMD Serono campaign for MS drug Mavenclad
Feb 20, 2025 1:11pm
Merck KGaA, analysts share optimism about potential CDMO rebound
Aug 7, 2024 3:13pm
After pulling Lumoxiti in Europe, AstraZeneca does same in US
Jan 13, 2023 10:15am
